A major advance in cancer research is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This essential malignant protector protein is frequently lost in many forms of malignancies, causing https://travialist.com/story12403759/nanobodies-reactivate-tumor-suppressor-p53-new-promising-approach-for-malignant-therapy